Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
INTS
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
☁️ News word cloud
Top words across the last 50 articles for this ticker.
nasdaq
trading
nyse
rating
compared
high
last
period
therapeutics
after
rose
holdings
market
intensity
stocks
previous
fell
friday
current
gained
52w low +4.7%
INTS
Intensity Therapeutics, Inc. Common stock
StonvexStonvexStonvexStonvex